Serialized Product Intelligence
Shift from a Reactive to a Proactive Serialized Supply Chain
Serialized Product Intelligence: Discover the Value of Your Serialization Data
Serialized Product Intelligence (SPI) is a new cloud application that provides actionable intelligence for your serialized drug supply chain. With SPI, pharmaceutical companies can proactively monitor their serialized drug supply chain, accelerate the resolution of inconsistencies, and strive for timely product delivery to the market.
How Companies Use Serialized Product Intelligence
Use Cases and Demos
Proactively Monitor Your Serialization Operations
Situation: A marketing authorization holder (MAH) relies on two contract manufacturing organizations (CMOs) to provide a life-critical product for a target market. The track & trace team experiences at least one serialization exception every month, which delays product delivery and affects sales.
Solution: With SPI, a serialization team monitors shipments, lots, batches, serial numbers, and serial number events with minimal data latency. The supplier relationship management team gets direct visibility into activities and actions of trading partners, including other MAHs, CMOs, and 3PLs (third-party logistics providers).
Business Value: By monitoring shipments and deliveries at different levels of aggregation, an MAH can reduce disruptions to its serialized supply chain to reduce sales losses, minimize the costs of disruptions, and improve product availability.
Perform Root Cause Analysis of Issues and Exceptions
Situation: A pharma manufacturer competes in multiple target markets. The company realizes that the manual troubleshooting of serialization exceptions and supply chain disruptions not only drains the serialization team’s time and resources but also delays shipments by days and even weeks. This situation often leads to the scrapping of valuable products that require special handling.
Solution: The serialization and supply chain teams use SPI to review all activities performed on each shipment, lot, batch, and serial number – from commissioning until product release. The team analyzes the root causes of disruptions and delays.
Business Value: The pharma manufacturer resolves issues and exceptions up to 75% faster than with a manual effort, helping to reduce delayed shipments and avoid blockage of products.
Enable Key Functions to Answer Business-Critical Questions from Your Serialization Data
Situation: A pharma enterprise delivers medicine across multiple continents. The track & trace and IT teams get inundated with ad hoc questions from other functions in the company, requiring the analysis of serialization data.
Solution: SPI enables key functions across the enterprise, such as supply chain, sales, quality, manufacturing, warehousing, and logistics, to answer business-critical questions by leveraging serialization data in a self-service manner.
Business Value: While reducing the workload of the track & trace and IT teams, a pharma company drives broader operational efficiencies and unlocks the value of the serialization data across the enterprise.
Gain Actionable Insights into Complex Reporting and Choreography in Markets Like Russia
Situation: A pharma manufacturer is preparing for track & trace readiness in a complex regulatory environment such as Russia. The evolving and uniquely complex compliance reporting and associated choreography affect the visibility into the serialized supply chain. The serialization and supply chain teams need to improve serialized supply chain visibility and product availability in a growing market.
Solution: Instead of reacting with delay to issues in each intermediate step that can cause compliance failures and omissions, teams proactively monitor deliveries, lots, batches, and serial numbers in line with the complex reporting required by Russia regulations.
Business Value: The pharma manufacturer avoids costly delays and disruptions that can occur in any step of the process of serializing medicines in Russia.